Larisa D.

Larisa D. is a seasoned finance professional with extensive experience in various controller and financial reporting roles within the biotechnology and pharmaceuticals industry. Currently serving as Controller at Viridian Therapeutics, Inc. since January 2022, Larisa has held similar positions at OncXerna Therapeutics, Chiasma, and Pear Therapeutics, where responsibilities included overseeing financial operations and reporting. Prior to these roles, Larisa contributed to financial reporting and accounting at Spero Therapeutics, AMAG Pharmaceuticals, Cubist Pharmaceuticals, and ImmunoGen. Larisa's academic credentials include an MBA in Accounting from Bentley University, an MS in International Economics and Finance from Brandeis University, and a Bachelor of Business Administration from Loyola University New Orleans.